Literature DB >> 11595650

A nonlabeled method to evaluate cortisol production rate by modeling plasma CBG-free cortisol disposition.

N Picard-Hagen1, V Gayrard, M Alvinerie, H Smeyers, R Ricou, A Bousquet-Melou, P L Toutain.   

Abstract

This study aimed to develop a nonlabeled method for the measurement of cortisol production rate to evaluate adrenal function. The cortisol production rate determination requires that of cortisol clearance, which is not a parameter but a variable resulting from the saturable binding of cortisol to corticosteroid-binding globulin (CBG). Our method is based on evaluation of the plasma clearance of the CBG-free cortisol fraction. This parameter was evaluated from a pharmacokinetic model of total plasma cortisol disposition that takes into account specific binding of the corticoid to CBG in the plasma. We have shown that the CBG-free cortisol kinetics and CBG-binding parameters thus evaluated are not statistically different from those obtained by the radioisotopic method and equilibrium dialysis, suggesting that the plasma CBG-free cortisol clearance is independent of the total plasma cortisol concentrations and represents the actual parameter of cortisol elimination. We validated this modeling approach by using it to calculate the in vivo entry rate of cortisol mimicked by the perfusion of cortisol at a known rate.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11595650     DOI: 10.1152/ajpendo.2001.281.5.E946

Source DB:  PubMed          Journal:  Am J Physiol Endocrinol Metab        ISSN: 0193-1849            Impact factor:   4.310


  12 in total

1.  Quantifying nonlinear interactions within the hypothalamo-pituitary-adrenal axis in the conscious horse.

Authors:  Daniel M Keenan; Sue Alexander; Clifford Irvine; Johannes D Veldhuis
Journal:  Endocrinology       Date:  2008-11-20       Impact factor: 4.736

Review 2.  Motivations and methods for analyzing pulsatile hormone secretion.

Authors:  Johannes D Veldhuis; Daniel M Keenan; Steven M Pincus
Journal:  Endocr Rev       Date:  2008-10-21       Impact factor: 19.871

3.  Reversible increase in maximal cortisol secretion rate in septic shock.

Authors:  Richard I Dorin; Clifford R Qualls; David J Torpy; Ronald M Schrader; Frank K Urban
Journal:  Crit Care Med       Date:  2015-03       Impact factor: 7.598

4.  Pharmacokinetics and pharmacodynamics of single rising intravenous doses (0.5 mg-10 mg) and determination of absolute bioavailability of the dipeptidyl peptidase-4 inhibitor linagliptin (BI 1356) in healthy male subjects.

Authors:  Silke Retlich; Vincent Duval; Arne Ring; Alexander Staab; Silke Hüttner; Arvid Jungnik; Ulrich Jaehde; Klaus A Dugi; Ulrike Graefe-Mody
Journal:  Clin Pharmacokinet       Date:  2010-12       Impact factor: 6.447

5.  Pharmacokinetic/Pharmacodynamic Modeling of Renin-Angiotensin Aldosterone Biomarkers Following Angiotensin-Converting Enzyme (ACE) Inhibition Therapy with Benazepril in Dogs.

Authors:  Jonathan P Mochel; Martin Fink; Mathieu Peyrou; Antoine Soubret; Jérôme M Giraudel; Meindert Danhof
Journal:  Pharm Res       Date:  2014-12-02       Impact factor: 4.200

6.  Population pharmacokinetic modelling of irosustat in postmenopausal women with oestrogen-receptor positive breast cancer incorporating non-linear red blood cell uptake.

Authors:  Zinnia P Parra-Guillen; Josep María Cendrós Carreras; Concepción Peraire; Rosendo Obach; Joan Prunynosa; Eric Chetaille; Iñaki F Trocóniz
Journal:  Pharm Res       Date:  2014-10-30       Impact factor: 4.200

7.  Prediction of Free from Total Mycophenolic Acid Concentrations in Stable Renal Transplant Patients: A Population-Based Approach.

Authors:  Helena Colom; Franc Andreu; Teun van Gelder; Dennis A Hesselink; Brenda C M de Winter; Oriol Bestard; Joan Torras; Josep M Cruzado; Josep M Grinyó; Núria Lloberas
Journal:  Clin Pharmacokinet       Date:  2018-07       Impact factor: 6.447

8.  Predicting Cortisol Exposure from Paediatric Hydrocortisone Formulation Using a Semi-Mechanistic Pharmacokinetic Model Established in Healthy Adults.

Authors:  Johanna Melin; Zinnia P Parra-Guillen; Niklas Hartung; Wilhelm Huisinga; Richard J Ross; Martin J Whitaker; Charlotte Kloft
Journal:  Clin Pharmacokinet       Date:  2018-04       Impact factor: 6.447

9.  Increased whole-body and sustained liver cortisol regeneration by 11beta-hydroxysteroid dehydrogenase type 1 in obese men with type 2 diabetes provides a target for enzyme inhibition.

Authors:  Roland H Stimson; Ruth Andrew; Norma C McAvoy; Dhiraj Tripathi; Peter C Hayes; Brian R Walker
Journal:  Diabetes       Date:  2011-01-24       Impact factor: 9.461

10.  Characterization of Cortisol Secretion Rate in Secondary Adrenal Insufficiency.

Authors:  Richard I Dorin; Zhi George Qiao; Matthew Bouchonville; Clifford R Qualls; Ronald M Schrader; Frank K Urban
Journal:  J Endocr Soc       Date:  2017-06-01
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.